BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease (COPD)

Overview

The main purpose of this study is to determine feasibility and effects of tai chi and mind-body breathing in patients with COPD.

Full Title of Study: “BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Other
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: April 2016

Interventions

  • Behavioral: Tai chi
    • 12 week tai chi class
  • Behavioral: Mind-body breathing
    • 12 week breathing class
  • Behavioral: Education
    • 12 week education class

Arms, Groups and Cohorts

  • Experimental: tai chi exercise
  • Experimental: mind-body breathing
  • Active Comparator: education

Clinical Trial Outcome Measures

Primary Measures

  • Feasibility of tai chi intervention
    • Time Frame: 12 weeks
    • Willingness to participate, adherence, and safety

Secondary Measures

  • Change from baseline- Disease specific quality of life
    • Time Frame: baseline, 12 weeks, 24 weeks
    • Chronic Respiratory Questionnaire
  • Change from baseline- Exercise capacity
    • Time Frame: baseline, 12 weeks, 24 weeks
    • six-minute walk distance, cardiopulmonary exercise testing
  • Change from baseline- Dyspnea
    • Time Frame: baseline, 12 weeks, 24 weeks
    • UCSD Shortness of Breath Questionnaire
  • Change from baseline- Psychosocial well-being
    • Time Frame: baseline, 12 weeks, 24 weeks
    • CES-D, Perceive Stress Scale, COPD Self-Efficacy Scale, Multidimensional Scale of Percieved Social Support
  • Change from baseline- Pulmonary function
    • Time Frame: baseline, 12 weeks, 24 weeks
    • Spirometry and lung volumes
  • Change from baseline- Physical strength and flexibility
    • Time Frame: baseline, 12 weeks, 24 weeks
    • Chair Sit and Reach, Chair Stand

Participating in This Clinical Trial

Inclusion Criteria

1. Moderate-severe COPD 2. Age ≥ 40 years Exclusion Criteria:

1. Subjects with respiratory failure or GOLD stage 4 who are unable to safely perform a 6 minute walk test or otherwise safely exercise as deemed by a physician. 2. COPD exacerbation requiring steroids, antibiotics, ED visit or hospitalization within the past 2 weeks unless physician deems subject at baseline 3. Planned major pulmonary intervention within the next 3 months 4. Hypoxemia on walk test or cardiopulmonary exercise test 5. Inability to ambulate due to vascular or other neuromuscular conditions that would preclude a walk test 6. Clinical signs of unstable cardiovascular disease 7. Severe cognitive dysfunction 8. Non-English speaking 9. Current active participation in pulmonary rehabilitation program or current regular practice of tai chi 10. Physician diagnosis of unstable/untreated clinical depression 11. History of lung cancer

Gender Eligibility: All

Minimum Age: 40 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Beth Israel Deaconess Medical Center
  • Collaborator
    • National Institutes of Health (NIH)
  • Provider of Information About this Clinical Study
    • Principal Investigator: Gloria Y. Yeh, Associate Professor of Medicine – Beth Israel Deaconess Medical Center
  • Overall Official(s)
    • Gloria Yeh, MD, MPH, Principal Investigator, BIDMC, Harvard Medical School

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.